Literature DB >> 26078380

Mucociliary clearance techniques for treating non-cystic fibrosis bronchiectasis: Is there evidence?

D Snijders1, B Fernandez Dominguez2, S Calgaro3, I Bertozzi3, A Escribano Montaner2, G Perilongo3, A Barbato3.   

Abstract

Non-cystic fibrosis bronchiectasis (nCFb) is an acquired condition of variable etiology. An impaired mucociliary clearance seems to be one of the mechanisms behind nCFb, and treatment involves antibiotics, mucoactive agents, and airway clearance techniques (ACTs). Traditional ACTs have four components: postural drainage, percussion, vibration of the chest wall, and coughing. Reviewing the international medical literature on the use of ACTs for patients with nCFb from 1989 to the present day, we retrieved 93 articles, of which 35 met our selection criteria for this analysis. We reviewed active cycle of breathing techniques (ACBT), forced expiration techniques (FET), autogenic drainage, postural drainage, oscillating positive expiratory pressure (OPep), high frequency chest wall oscillation (HFCWO), and exercise or pulmonary rehabilitation. Overall, ACTs appear to be safe for individuals (adults and children) with stable bronchiectasis; where there may be improvements in sputum expectoration, selected measures of lung function, and health-related quality of life. Unfortunately, there is a lack of RCTs in nCFb patients, especially in children. Moreover, none of the studies describes long-term effects of ACTs. It should be noted that a single intervention might not reflect the longer-term outcome and there is no evidence to recommend or contest any type of ACTs in nCFb management. Multicenter RCTs are necessary to evaluate the different techniques of ACTs especially in children with nCFb.
© The Author(s) 2015.

Entities:  

Keywords:  airway clearance techniques; chest physiotherapy; non-CF bronchiectasis

Mesh:

Year:  2015        PMID: 26078380     DOI: 10.1177/0394632015584724

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  8 in total

1.  Essentials in the Comprehensive Management of Chronic Respiratory Diseases: Airway Clearance and Vaccination.

Authors:  Aslı Görek Dilektaşlı; Zeynep Pınar Önen
Journal:  Turk Thorac J       Date:  2018-07-01

Review 2.  Review: Quality of Life in Children with Non-cystic Fibrosis Bronchiectasis.

Authors:  Anna Marie Nathan; Jessie Anne de Bruyne; Kah Peng Eg; Surendran Thavagnanam
Journal:  Front Pediatr       Date:  2017-04-24       Impact factor: 3.418

Review 3.  The Likelihood of Preventing Respiratory Exacerbations in Children and Adolescents with either Chronic Suppurative Lung Disease or Bronchiectasis.

Authors:  Kerry-Ann F O'Grady; Keith Grimwood
Journal:  Front Pediatr       Date:  2017-03-24       Impact factor: 3.418

Review 4.  A pediatric disease to keep in mind: diagnostic tools and management of bronchiectasis in pediatric age.

Authors:  Marcella Gallucci; Emanuela di Palmo; Luca Bertelli; Federica Camela; Giampaolo Ricci; Andrea Pession
Journal:  Ital J Pediatr       Date:  2017-12-29       Impact factor: 2.638

Review 5.  Non-antimicrobial airway management of non-cystic fibrosis bronchiectasis.

Authors:  Ashley M Egan; Jeremy M Clain; Patricio Escalante
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2017-12-12

6.  Physiotherapists' use of airway clearance techniques during an acute exacerbation of bronchiectasis: a survey study.

Authors:  Jennifer Phillips; Annemarie Lee; Rodney Pope; Wayne Hing
Journal:  Arch Physiother       Date:  2021-02-01

7.  Effects of a Mixture of Ivy Leaf Extract and Coptidis rhizome on Patients with Chronic Bronchitis and Bronchiectasis.

Authors:  Goohyeon Hong; Yu-Il Kim; Seoung Ju Park; Sung Yong Lee; Jin Woo Kim; Seong Hoon Yoon; Keu Sung Lee; Min Kwang Byun; Hak-Ryul Kim; Jaeho Chung
Journal:  Int J Environ Res Public Health       Date:  2021-04-12       Impact factor: 3.390

8.  Chest physiotherapy for pneumonia in children.

Authors:  Gabriela Ss Chaves; Diana A Freitas; Thayla A Santino; Patricia Angelica Ms Nogueira; Guilherme Af Fregonezi; Karla Mpp Mendonça
Journal:  Cochrane Database Syst Rev       Date:  2019-01-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.